2940 Phase I Study of Tq-B3101 in Pediatric Patients with Relapsed/Refractory Anaplastic Lymphoma Kinase Positive Anaplastic Large Cell Lymphoma
Published date:
11/03/2022
Excerpt:
The ORR was 100%, with four patients achieving complete response (CR) and three patients achieving a partial response (PR)….Our preliminary results suggest that TQ-B3101 has significant clinical activity in children with R/R ALK+ ALCL. Responses were durable and ongoing, and treatment was well tolerated.